Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
G Rosti, F Castagnetti, G Gugliotta… - Nature reviews clinical …, 2017 - nature.com
The therapeutic armamentarium for chronic myeloid leukaemia (CML) comprises mainly
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
Tyrosine kinase inhibitors in chronic myeloid leukaemia: Which, when, for whom?
G Rosti, F Castagnetti, G Gugliotta… - NATURE REVIEWS …, 2017 - cris.unibo.it
The therapeutic armamentarium for chronic myeloid leukaemia (CML) comprises mainly
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
G Rosti, F Castagnetti, G Gugliotta… - Nature Reviews Clinical …, 2017 - go.gale.com
The therapeutic armamentarium for chronic myeloid leukaemia (CML) comprises mainly
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
G Rosti, F Castagnetti, G Gugliotta… - Nature reviews. Clinical …, 2016 - europepmc.org
The therapeutic armamentarium for chronic myeloid leukaemia (CML) comprises mainly
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
[引用][C] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
G Rosti, F Castagnetti, G Gugliotta… - Nature Reviews Clinical …, 2016 - cir.nii.ac.jp
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom? | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
G Rosti, F Castagnetti, G Gugliotta… - Nature reviews …, 2017 - pubmed.ncbi.nlm.nih.gov
The therapeutic armamentarium for chronic myeloid leukaemia (CML) comprises mainly
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …
tyrosine kinase inhibitors (TKIs), with several agents available for frontline treatment, or for …